Total submissions: 26
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Dr. |
RCV005931148 | SCV006666138 | not provided | Ovarian cancer | no classification provided | in vitro | ||
| Dr. |
RCV005931148 | SCV006666137 | not provided | Ovarian cancer | no classification provided | in vitro | ||
| Dr. |
RCV005931148 | SCV006666136 | not provided | Ovarian cancer | no classification provided | in vitro | ||
| Dr. |
RCV005931151 | SCV006666135 | not provided | Lymphoma | no classification provided | in vitro | ||
| Dr. |
RCV005931151 | SCV006666134 | not provided | Lymphoma | no classification provided | in vitro | ||
| Dr. |
RCV005931151 | SCV006666133 | not provided | Lymphoma | no classification provided | in vitro | ||
| Dr. |
RCV005931151 | SCV006666131 | not provided | Lymphoma | no classification provided | in vitro | ||
| Dr. |
RCV005931147 | SCV006666130 | not provided | Nonpapillary renal cell carcinoma | no classification provided | in vitro | ||
| Dr. |
RCV005931147 | SCV006666129 | not provided | Nonpapillary renal cell carcinoma | no classification provided | in vitro | ||
| Dr. |
RCV005931155 | SCV006666128 | not provided | Chronic lymphocytic leukemia/small lymphocytic lymphoma | no classification provided | in vitro | ||
| Dr. |
RCV005931153 | SCV006666127 | not provided | Cholangiocarcinoma | no classification provided | in vitro | ||
| Dr. |
RCV005931153 | SCV006666126 | not provided | Cholangiocarcinoma | no classification provided | in vitro | ||
| Dr. |
RCV005931153 | SCV006666125 | not provided | Cholangiocarcinoma | no classification provided | in vitro | ||
| Dr. |
RCV005931152 | SCV006666124 | not provided | Thymoma | no classification provided | in vitro | ||
| Dr. |
RCV005931152 | SCV006666123 | not provided | Thymoma | no classification provided | in vitro | ||
| Dr. |
RCV005931147 | SCV006666122 | not provided | Nonpapillary renal cell carcinoma | no classification provided | in vitro | ||
| Dr. |
RCV005931150 | SCV006666120 | not provided | Malignant lymphoma, large B-cell, diffuse | no classification provided | in vitro | ||
| Dr. |
RCV005931154 | SCV006666119 | not provided | Uterine corpus endometrial carcinoma | no classification provided | in vitro | ||
| Dr. |
RCV005931154 | SCV006666118 | not provided | Uterine corpus endometrial carcinoma | no classification provided | in vitro | ||
| Dr. |
RCV005931154 | SCV006666117 | not provided | Uterine corpus endometrial carcinoma | no classification provided | in vitro | ||
| Dr. |
RCV005931146 | SCV006666116 | not provided | Colon adenocarcinoma | no classification provided | in vitro | ||
| Dr. |
RCV005931146 | SCV006666115 | not provided | Colon adenocarcinoma | no classification provided | in vitro | ||
| Dr. |
RCV005931146 | SCV006666114 | not provided | Colon adenocarcinoma | no classification provided | in vitro | ||
| Dr. |
RCV005931149 | SCV006666113 | not provided | Clear cell carcinoma of kidney | no classification provided | in vitro | ||
| Dr. |
RCV005931149 | SCV006666112 | not provided | Clear cell carcinoma of kidney | no classification provided | in vitro | ||
| HLA Laboratory, |
RCV003993689 | SCV004041892 | uncertain significance | COPD, severe early onset | 2023-08-10 | no assertion criteria provided | research |